Association of apolipoprotein E polymorphisms in patients with non-alcoholic steatohepatitis

Digestive Diseases and Sciences

Volumn 53, Issue 12, 2008, Pages 3218-3224

  Sazci, Ali ^a   Akpinar, Gurler ^a   Aygun, Cem ^a   Ergul, Emel ^a   Senturk, Omer ^a   Hulagu, Sadettin ^a  

^a KOCAELI UNIVERSITY   (Turkey)

Author keywords

APOE polymorphism; Association; NAFLD; NASH; Turkey

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; APOLIPOPROTEIN E; APOLIPOPROTEIN E3; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CYANOCOBALAMIN; FERRITIN; FOLIC ACID; GLUCOSE; HOMOCYSTEINE; INSULIN; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PROTEIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ALLELE; AMINO ACID BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BODY MASS; CASE CONTROL STUDY; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; FERRITIN BLOOD LEVEL; FOLIC ACID BLOOD LEVEL; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; LIPID BLOOD LEVEL; LIVER BIOPSY; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TRIACYLGLYCEROL BLOOD LEVEL; VITAMIN BLOOD LEVEL; WAIST CIRCUMFERENCE;

ADOLESCENT; ADULT; AGED; APOLIPOPROTEIN E3; APOLIPOPROTEINS E; CASE-CONTROL STUDIES; COHORT STUDIES; FATTY LIVER; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HEPATITIS; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; TURKEY; YOUNG ADULT;

EID: 55949083698     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-008-0271-5     Document Type: Article

References (48)

1. J Ludwig TR Viggiano DB McGill BJ Oh 1980 Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease Mayo Clin Proc 55 434 438
2. P Angulo 2002 Nonalcoholic fatty liver disease N Engl J Med 346 1221 1231 10.1056/NEJMra011775
3. N Assy K Kaita D Mymin C Levy B Rosser G Minuk 2000 Fatty infiltration of liver in hyperlipidemic patients Dig Dis Sci 45 1929 1934 10.1023/A: 1005661516165
4. G Marchesini M Brizi AM Morselli-Labate G Bianchi E Bugianesi AJ McCullough G Forlani N Melchionda 1999 Association of nonalcoholic fatty liver disease with insulin resistance Am J Med 107 450 455 10.1016/S0002-9343(99) 00271-5
5. K Mehta DH Van Thiel N Shah S Mobarhan 2002 Nonalcoholic fatty liver disease: pathogenesis and the role of antioxidants Nutr Rev 60 289 293 10.1301/002966402320387224
6. J Grove AS Brown AK Daly MF Bassendine OF James CP Day 1998 The RsaI polymorphism of CYP2E1 and susceptibility to alcoholic liver disease in Caucasians: effect on age of presentation and dependence on alcohol dehydrogenase genotype Pharmacogenetics 8 335 342 10.1097/00008571-199808000- 00007
7. T Ohnishi Y Ogawa T Saibara A Nishioka S Kariya M Fukumoto S Onishi S Yoshida 2005 CYP17 polymorphism and tamoxifen-induced hepatic steatosis Hepatol Res 33 178 180 10.1016/j.hepres.2005.09.030
8. JP Nolan 1989 Intestinal endotoxins as mediators of hepatic injury-an idea whose time has come again Hepatology 10 887 891 10.1002/hep.1840100523
9. G Tiegs 1994 Immunotoxicology of host-response-mediated experimental liver injury J Hepatol 21 890 903 10.1016/S0168-8278(94)80256-4
10. DK George S Goldwurm GA MacDonald LL Cowley NI Walker PJ Ward EC Jazwinska LW Powell 1998 Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis Gastroenterology 114 311 318 10.1016/S0016-5085(98)70482-2
11. AJ Wigg IC Roberts-Thomson RB Dymock PJ McCarthy RH Grose AG Cummins 2001 The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis Gut 48 206 211 10.1136/gut.48.2.206
12. Z Li S Yang H Lin J Huang PA Watkins AB Moser C Desimone XY Song AM Diehl 2003 Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease Hepatology 37 343 350 10.1053/jhep.2003.50048
13. G Utermann M Hees A Steinmetz 1977 Polymorphism of apolipoprotein E and occurrence of dysbetalipoproteinaemia in man Nature 269 604 607 10.1038/269604a0
14. VI Zannis JL Breslow G Utermann RW Mahley KH Weisgraber RJ Havel JL Goldstein MS Brown G Schonfeld WR Hazzard C Blum 1982 Proposed nomenclature of apoE isoproteins, apoE genotypes, and phenotypes J Lipid Res 23 911 914
15. WJ Strittmatter AM Saunders D Schmechel M Pericak-Vance J Enghild GS Salvesen AD Roses 1993 Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease Proc Natl Acad Sci USA 90 5 1977 1981 10.1073/pnas.90.5.1977
16. BA Parmenter DR Denney SG Lynch LS Middleton LM Harlan 2007 Cognitive impairment in patients with multiple sclerosis: association with the APOE gene and promoter polymorphisms Mult Scler 13 1 25 32 10.1177/1352458506070682
17. A Pezzini M Grassi E Del Zotto E Bazzoli S Archetti D Assanelli NM Akkawi A Albertini A Padovani 2004 Synergistic effect of apolipoprotein E polymorphisms and cigarette smoking on risk of ischemic stroke in young adults Stroke 35 2 438 442 10.1161/01.STR.0000112973.00867.98
18. YJ Li MA Pericak-Vance JL Haines N Siddique D McKenna-Yasek WY Hung P Sapp CI Allen W Chen B Hosler AM Saunders LM Dellefave RH Brown T Siddique 2004 Apolipoprotein E is associated with age at onset of amyotrophic lateral sclerosis Neurogenetics 5 4 209 213 10.1007/s10048-004-0193-0
19. I Rainero LME Grimaldi G Salani W Valfrè L Savi C Rivoiro S Gentile L Pinessi 2002 Apolipoprotein E gene polymorphisms in patients with migraine Neurosci Lett 317 111 113 10.1016/S0304-3940(01)02432-6
20. SA Miller DD Dykes HF Polesky 1988 A simple salting out procedure for extracting DNA from human nucleated cells Nucleic Acids Res 16 1215 10.1093/nar/16.3.1215
21. PR Wenham WH Price G Blundel 1991 Apolipoprotein E genotyping by one-stage PCR Lancet 337 1158 1159 10.1016/0140-6736(91)92823-K
22. A Sazci E Ergul G Kaya I Kara 2005 Genotype and allele frequencies of the polymorphic methylenetetrahydrofolate reductase gene in Turkey Cell Biochem Funct 23 51 54 10.1002/cbf.1132
23. EM Brunt CG Janney AM Di Bisceglie BA Neuschwander-Tetri BR Bacon 1999 Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions Am J Gastroenterol 94 2467 2474 10.1111/j.1572-0241.1999. 01377.x
24. DE Kleiner EM Brunt M Van Natta C Behling MJ Contos OW Cummings LD Ferrell YC Liu MS Torbenson A Unalp-Arida M Yeh AJ McCullough AJ Sanyal Nonalcoholic steatohepatitis Clinical Research Network 2005 Design and validation of a histological scoring system for nonalcoholic fatty liver disease Hepatology 41 1313 1321 10.1002/hep.20701
25. MD Demirag HI Onen MY Karaoguz I Dogan T Karakan A Ekmekci G Guz 2007 Apolipoprotein E gene polymorphism in nonalcoholic fatty liver disease Dig Dis Sci 52 12 3399 3403 10.1007/s10620-007-9740-5
26. DA Price MF Bassendine SM Norris C Golding GL Toms ML Schmid CM Morris AD Burt PT Donaldson 2006 Apolipoprotein epsilon3 allele is associated with persistent hepatitis C virus infection Gut 55 715 718 10.1136/gut.2005.079905
27. MH Yang HJ Son JD Sung YH Choi KC Koh BC Yoo SW Paik 2005 The relationship between apolipoprotein E polymorphism, lipoprotein (a) and fatty liver disease Hepatogastroenterology 52 1832 1835
28. M Yoshimatsu Y Terasaki N Sakashita E Kiyota H Sato LJ van der Laan M Takeya 2004 Induction of macrophage scavenger receptor MARCO in nonalcoholic steatohepatitis indicates possible involvement of endotoxin in its pathogenic process Int J Exp Pathol 85 335 343 10.1111/j.0959-9673.2004.00401.x
29. JL Miller 2003 Insulin resistance syndrome. Description, pathogenesis, and management Postgrad Med 113 27 34
30. G Marchesini E Bugianesi G Forlani F Cerrelli M Lenzi R Manini S Natale E Vanni N Villanova N Melchionda M Rizzetto 2003 Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome Hepatology 37 917 923 10.1053/jhep.2003.50161
31. BL Wajchenberg D Giannella-Neto ME da Silva RF Santos 2002 Depot-specific hormonal characteristics of subcutaneous and visceral adipose tissue and their relation to the metabolic syndrome Horm Metab Res 34 616 621 10.1055/s-2002-38256
32. T Yamauchi J Kamon H Waki Y Terauchi N Kubota K Hara Y Mori T Ide K Murakami N Tsuboyama-Kasaoka O Ezaki Y Akanuma O Gavrilova C Vinson ML Reitman H Kagechika K Shudo M Yoda Y Nakano K Tobe R Nagai S Kimura M Tomita P Froguel T Kadowaki 2001 The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity Nat Med 7 941 946 10.1038/90984
33. J Hirosumi G Tuncman L Chang CZ Görgün KT Uysal K Maeda M Karin GS Hotamisligil 2002 A central role for JNK in obesity and insulin resistance Nature 420 333 336 10.1038/nature01137
34. Y Huang XQ Liu SC Rall Jr JM Taylor A von Eckardstein G Assmann RW Mahley 1998 Overexpression and accumulation of apolipoprotein E as a cause of hypertriglyceridemia J Biol Chem 273 26388 26393 10.1074/jbc.273.41.26388
35. CP Day OF James 1998 Steatohepatitis: a tale of two "hits"? Gastroenterology 114 842 845 10.1016/S0016-5085(98)70599-2
36. V Goossens J Grooten K De Vos W Fiers 1995 Direct evidence for tumor necrosis factor-induced mitochondrial reactive oxygen intermediates and their involvement in cytotoxicity Proc Natl Acad Sci USA 92 8115 8119 10.1073/pnas.92.18.8115
37. D Pessayre A Mansouri B Fromenty 2002 Nonalcoholic steatosis and steatohepatitis. V. Mitochondrial dysfunction in steatohepatitis Am J Physiol Gastrointest Liver Physiol 282 G193 G199
38. R Shiri-Sverdlov K Wouters PJ van Gorp MJ Gijbels B Noel L Buffat B Staels N Maeda M van Bilsen MH Hofker 2006 Early diet-induced non-alcoholic steatohepatitis in APOE2 knock-in mice and its prevention by fibrates J Hepatol 44 732 741 10.1016/j.jhep.2005.10.033
39. SM Lessner HL Prado EK Waller ZS Galis 2002 Atherosclerotic lesions grow through recruitment and proliferation of circulating monocytes in a murine model Am J Pathol 160 2145 2155
40. DJ Grainger J Reckless E McKilligin 2004 Apolipoprotein E modulates clearance of apoptotic bodies in vitro and in vivo, resulting in a systemic proinflammatory state in apolipoprotein E-deficient mice J Immunol 173 6366 6375
41. M Tous N Ferré J Camps F Riu J Joven 2005 Feeding apolipoprotein E-knockout mice with cholesterol and fat enriched diets may be a model of non-alcoholic steatohepatitis Mol Cell Biochem 268 53 58 10.1007/s11010-005- 2997-0
42. AR Mensenkamp MJ Van Luyn R Havinga B Teusink IJ Waterman CJ Mann BM Elzinga HJ Verkade VA Zammit LM Havekes CC Shoulders F Kuipers 2004 The transport of triglycerides through the secretory pathway of hepatocytes is impaired in apolipoprotein E deficient mice J Hepatol 40 599 606 10.1016/j.jhep.2003.12.011
43. T Demant D Bedford CJ Packard J Shepherd 1991 Influence of apolipoprotein E polymorphism on apolipoprotein B-100 metabolism in normolipemic subjects J Clin Invest 88 1490 1501 10.1172/JCI115459
44. FK Welty AH Lichtenstein PH Barrett JL Jenner GG Dolnikowski EJ Schaefer 2000 Effects of ApoE genotype on ApoB-48 and ApoB-100 kinetics with stable isotopes in humans Arterioscler Thromb Vasc Biol 20 807 1810
45. FM Riches GF Watts FM van Bockxmeer J Hua S Song SE Humphries PJ Talmud 1998 Apolipoprotein B signal peptide and apolipoprotein E genotypes as determinants of the hepatic secretion of VLDL apoB in obese men J Lipid Res 39 1752 1758
46. AR Mensenkamp LM Havekes JA Romijn F Kuipers 2001 Hepatic steatosis and very low density lipoprotein secretion: the involvement of apolipoprotein E J Hepatol 35 816 822 10.1016/S0168-8278(01)00249-5
47. Sazci A, Akpinar G, Aygun C, Ergul E, Senturk O, Hulagu S (2006) Apolipoprotein E polymorphisms in patients with non-alcoholic steatohepatitis (NASH). J Hepatol 44:S263-S263 715 Suppl. 2
48. M Kasap A Sazci G Akpinar E Ergul 2008 Apolipoprotein E phylogeny and evolution Cell Biochem Funct 26 1 43 50 10.1002/cbf.1396